As per this study, the Global Radiopharmaceutical/Nuclear Medicine Market was valued USD XX BN (by revenue) in 2021 and is anticipated to reach USD XX BN by 2028 with a CAGR of X%.
Radiopharmaceutical/nuclear medicine refers to a radioactive drug used for monitoring and treating patients suffering from cancer, heart related problems, and neural issues. The trace amount of radioisotope present in the medicine binds the organic compound, which is later conveyed, to the target cell, tissue or organ. The rays emitted by radioisotope are detected by specific imaging device. The gamma rays are used for diagnostic purpose whereas short-range alpha or beta rays are used for treatment purpose.
Market Dynamics
Rising commonness of cancer and cardiovascular diseases has led the demand for nuclear medicine. Increasing spending on healthcare followed by rising awareness regarding the medicine is also contributing the market growth. Owing to non-invasive treatment, radiopharmaceutical/nuclear medicine is gaining major traction. However, short-term time of nuclear medicine is likely to hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of radiopharmaceutical/nuclear medicine.
Market Segmentation
The broad radiopharmaceutical/nuclear medicine market has been sub-grouped into type, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- PETRadiopharmaceuticals
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
By Application
- Diagnostic Application
- SPECT Application
- Cardiology
- Lymphoma
- Neurology
- Thyroid
- Other
- PET Application
- Oncology
- Cardiology
- Neurology
- Other
- Therapeutic Application
- Thyroid
- Bone Metastasis
- Lymphoma
- Endocrine Tumor
- Other Therapeutic Application
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for radiopharmaceutical/nuclear medicine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Radiopharmaceutical/Nuclear Medicine Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the radiopharmaceutical/nuclear medicine market include Advanced Accelerator Applications, Bayer, Bracco Imaging, Cardinal Health, Curium, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Lantheus Medical Imaging and Nordion among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . RADIOPHARMACEUTICAL/NUCLEAR MEDICINE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY TYPE
6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Diagnostic Nuclear Medicine Historic and Forecast Sales by Regions
6.6 Therapeutic Nuclear Medicine Historic and Forecast Sales by Regions
7 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Diagnostic Application Historic and Forecast Sales by Regions
7.5 Therapeutic Application Historic and Forecast Sales by Regions
8 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1. Overview, Historic and Forecast Sales Analysis
8.3.2. North America By Segment Sales Analysis
8.3.3. North America By Country Sales Analysis
8.3.4. United State Sales Analysis
8.3.5. Canada Sales Analysis
8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1. Overview, Historic and Forecast Sales Analysis
8.4.2. Europe by Segment Sales Analysis
8.4.3. Europe by Country Sales Analysis
8.4.4. United Kingdom Sales Analysis
8.4.5. France Sales Analysis
8.4.6. Germany Sales Analysis
8.4.7. Italy Sales Analysis
8.4.8. Russia Sales Analysis
8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1. Overview, Historic and Forecast Sales Analysis
8.5.2. Asia Pacific by Segment Sales Analysis
8.5.3. Asia Pacific by Country Sales Analysis
8.5.4. China Sales Analysis
8.5.5. India Sales Analysis
8.5.6. Japan Sales Analysis
8.5.7. South Korea Sales Analysis
8.5.8. Australia Sales Analysis
8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1. Overview, Historic and Forecast Sales Analysis
8.6.2. Latin America by Segment Sales Analysis
8.6.3. Latin America by Country Sales Analysis
8.6.4. Brazil Sales Analysis
8.6.5. Argentina Sales Analysis
8.6.6. Peru Sales Analysis
8.6.7. Chile Sales Analysis
8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1. Overview, Historic and Forecast Sales Analysis
8.7.2. Middle East & Africa by Segment Sales Analysis
8.7.3. Middle East & Africa by Country Sales Analysis
8.7.4. Saudi Arabia Sales Analysis
8.7.5. UAE Sales Analysis
8.7.6. Israel Sales Analysis
8.7.7. South Africa Sales Analysis
8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE RADIOPHARMACEUTICAL/NUCLEAR MEDICINE COMPANIES
9.1. Radiopharmaceutical/Nuclear Medicine Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF RADIOPHARMACEUTICAL/NUCLEAR MEDICINE INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Advanced Accelerator Applications
10.3.1. Company Overview
10.3.2. Company Revenue
10.3.3. Products
10.3.4. Recent Developments
10.4. Bayer
10.4.1. Company Overview
10.4.2. Company Revenue
10.4.3. Products
10.4.4. Recent Developments
10.5. Bracco Imaging
10.5.1. Company Overview
10.5.2. Company Revenue
10.5.3. Products
10.5.4. Recent Developments
10.6. Cardinal Health
10.6.1. Company Overview
10.6.2. Company Revenue
10.6.3. Products
10.6.4. Recent Developments
10.7. Curium
10.7.1. Company Overview
10.7.2. Company Revenue
10.7.3. Products
10.7.4. Recent Developments
10.8. Eczacibasi-Monrol Nuclear Products
10.8.1. Company Overview
10.8.2. Company Revenue
10.8.3. Products
10.8.4. Recent Developments
10.9. GE Healthcare
10.9.1. Company Overview
10.9.2. Company Revenue
10.9.3. Products
10.9.4. Recent Developments
10.10. Lantheus Medical Imaging
10.10.1. Company Overview
10.10.2. Company Revenue
10.10.3. Products
10.10.4. Recent Developments
10.11. Nordion
10.11.1. Company Overview
10.11.2. Company Revenue
10.11.3. Products
10.11.4. Recent Developments
10.12. Others
10.12.1. Company Overview
10.12.2. Company Revenue
10.12.3. Products
10.12.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Type (USD MN)
- Diagnostic Nuclear Medicine Market Sales by Geography (USD MN)
- Therapeutic Nuclear Medicine Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Diagnostic Application Market Sales by Geography (USD MN)
- Therapeutic Application Market Sales by Geography (USD MN)
- Global Radiopharmaceutical/Nuclear Medicine Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Radiopharmaceutical/Nuclear Medicine Report
- Market Research Process
- Market Research Methodology
- Global Radiopharmaceutical/Nuclear Medicine Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- Diagnostic Nuclear Medicine Market Sales by Geography (USD MN)
- Therapeutic Nuclear Medicine Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Diagnostic Application Market Sales by Geography (USD MN)
- Therapeutic Application Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Companies Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.